Elisha Butler

Elisha Butler is a seasoned pharmaceutical executive currently serving as the Head of Commercial Affairs and Strategy for South East Asia at Novo Nordisk, a position he has held since April 2023. Prior to this role, he was the Global Vice President for Alzheimer's Disease at Novo Nordisk from January 2021 to April 2023. His extensive experience in the pharmaceutical industry includes significant roles at Lundbeck, where he served as Global Marketing Director for various products including Eptinezumab and Abilify Maintena.1

Professional Background

• Current Position: Head of Commercial Affairs and Strategy, South East Asia at Novo Nordisk (April 2023 - Present)
• Previous Position: Global Vice President, Alzheimer's Disease at Novo Nordisk (January 2021 - April 2023)
• Other Roles at Lundbeck:
  • Global Marketing Director, Eptinezumab (October 2019 - January 2021)
  • Global Marketing Director, Abilify Maintena (October 2017 - October 2019)
  • Head of Marketing (January 2017 - October 2017)
  • Various marketing and sales roles from March 2013 to December 2016

Education

• University of Sydney: Bachelor of Science and Bachelor of Arts in Biochemistry, Pharmacology, and Asian Studies (2002 - 2006)
• Monte Sant' Angelo Mercy College: High School (1997 - 2001)

Recognition

Elisha Butler was recognized in the Berlingske Talent 100, which highlights young talents in Denmark under the age of 35 across various fields, showcasing his influence and contributions to the industry.1

His leadership is characterized by a strong focus on achieving excellence and results in the treatment of central nervous system disorders, particularly in psychiatry and neurology.